Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US
Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase III Toronto, Ontario--(Newsfile Corp. - July 5,...
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid
Nanalysis Arranges $8-Million Public offering
Asia Green Director Kingma's Diluted Holdings At 43.51%
Bloom Health Wins COVID-19 Testing Contract With Texas
Innocan Opens Its First Drug Research Lab In Jerusalem
Vigil Health to be acquired by Abloy for $12.55M